Concepedia

Adele Busico

AB

37

Publications

2.3K

Citations

25

H-Index

2013

Active since

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

University of Milan

Istituto Oncologico Veneto

University of Pisa

Azienda Ospedaliera Universitaria Pisana

Adele Busico is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2013–2023

37

Publications

37

Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan

Chiara Cremolini, Daniele Rossini, Emanuela Dell’Aquila et al. · JAMA Oncology · 2018 · 397 citations · Full text

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

Filippo Pietrantonio, Claudio Vernieri, Giulia Siravegna et al. · Clinical Cancer Research · 2016 · 177 citations · Full text

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O<sup>6</sup>-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: The MAYA Trial

Federica Morano, Alessandra Raimondi, Filippo Pagani et al. · Journal of Clinical Oncology · 2022 · 120 citations · Full text

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case–control study

Chiara Cremolini, Federica Morano, Roberto Moretto et al. · Annals of Oncology · 2017 · 116 citations · Full text

, , +8

Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study

Filippo Pietrantonio, Giovanni Fucà, Federica Morano et al. · Clinical Cancer Research · 2017 · 107 citations · Full text

Rows per page

1–5 of 37